Table4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image3_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tif by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table2_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Image1_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.tiff by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Table4_Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis.docx by Jiao Wang (47178)

“…Furthermore, the epidermal thickness decreased more after SHI or DMA treatment than in the control group (MD = -34.42, 95%CI [-41.25, -27.59], p < 0.00001, I² = 93%). …”

Removing an Ectopic Cystic Parathyroid Adenoma in the Anterior Mediastinum via Robotic-Assisted Thoracoscopic Surgery by Michael Tyler Guinn (14783498)

“…Hemostasis was confirmed, and a 19 French Blake drain was passed into the pleural space. …”

LRIG1 and CDK6 expression in the lateral ventricular wall cells by Hyung-song Nam (8914220)

DataSheet_1_Dissection of the Pre-Germinal Center B-Cell Maturation Pathway in Common Variable Immunodeficiency Based on Standardized Flow Cytometric EuroFlow Tools.pdf by Lucía del Pino-Molina (5213879)

“…These consisted of: i) a normally-appearing maturation pathway with altered levels of expression of >1 (CD38, CD5, CD19, CD21, CD24, and/or smIgM) phenotypic marker (57/88 patients; 65%) for a total of 3 distinct CVID patient profiles (group 1: 42/88 patients, 48%; group 2: 8/88, 9%; and group 3: 7/88, 8%) and ii) CVID patients with a clearly altered pre-GC B cell maturation pathway in blood (group 4: 31/88 cases, 35%).…”

Mutations of SWI/SNF components and the small ribosomal subunit Rps2 result in elevated noise. by Shu-Ting You (140787)

“…<p>(A) Attenuating <i>RPS2</i>, <i>SNF2</i>, or <i>SNF5</i> gene expression in the ancestral background results in increased noise (one-sided Wilcoxon rank-sum test, <i>n</i> = 6–19; <i>p</i> = 0.0039 for <i>rps2</i>-DAmP/+, <i>p</i> = 0.0025 for <i>snf2</i>Δ/+, <i>p</i> = 0.0008 for <i>snf5</i>Δ/+). …”

Complementary conditioning measures in healthy subjects. by Gabriela Ribeiro (4748373)

“…<p>Across conditioning for CS^- and CS⁺ flavors, ratings did not vary according to stimulus or conditioning day for (<b>A</b>) <b>Hunger</b> (Stimulus: F_(1,102) = 0.04, <i>P</i> = 0.8; Day: F_{(1, 102)} = 3.0, <i>P</i> = 0.08; Interaction: F_(1,102) = 9.9, <i>P</i> = 0.9), <b>(B) Thirst</b> (Stimulus: F_(1,102) = 0.1, <i>p</i> = 0.8; Day: F_{(1, 102)} = 3.2, <i>P</i> = 0.07; Interaction: F_(1,102) = 0.08, <i>P</i> = 0.8), (<b>C</b>) <b>Novelty</b> (Stimulus: F_(1,102) = 0.002, <i>P</i> = 0.9; Day: F_{(1, 102)} = 2.7, <i>P</i> = 0.1; Interaction: F_(1,102) = 1.3, <i>P</i> = 0.3), (<b>D</b>) <b>Intensity</b> (Stimulus: F_(1,99) = 0.3, <i>P</i> = 0.6; Day: F_{(1, 99)} = 0.09, <i>P</i> = 0.8; Interaction: F_(1,99) = 1.2, <i>P</i> = 0.3), and (<b>E</b>) <b>Pleasantness</b> (Stimulus: F_(1,98) = 0.9, <i>P</i> = 0.3; Day: F_(1,98)) = 0.4, <i>P</i> = 0.5; Interaction: F_(1,98) = 1.9, <i>P</i> = 0.2). …”

The CCDC66 depletion disrupts endocytosis and membrane recycling near cilia. by Jovana Deretic (13113617)

“…Mean ciliary fluorescence density of SMO in CCDC66 depletion after Taxol treatment is decreased to 0.72-fold of the control mean (compared to 0.33-fold without Taxol in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003313#pbio.3003313.g007" target="_blank">Fig 7</a>). …”

Destabilisation and inactivation of foam and foam-forming microorganisms in poultry slaughterhouse wastewater by Cynthia Dlangamandla (14765953)

“…The highest biodefoamer reduction of NH4+-N from 49 mg/L to 15.8 mg/L was observed at 216 h with FOG decreasing from a concentration of 170 mg/L to 6 mg/L. …”

Image 1_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Furthermore, E2 treatment enhanced the subsets of CD19+ IgD- memory B cells 4-weeks post immunization within the iLN and spleen. …”

Image 2_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Furthermore, E2 treatment enhanced the subsets of CD19+ IgD- memory B cells 4-weeks post immunization within the iLN and spleen. …”

Image 5_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Furthermore, E2 treatment enhanced the subsets of CD19+ IgD- memory B cells 4-weeks post immunization within the iLN and spleen. …”

Image 3_Estradiol enhances B cell humoral immune responses against genital herpes simplex virus type 2 in mice through an IL-17 dependant pathway.tiff by M. Firoz Mian (10013314)

“…Furthermore, E2 treatment enhanced the subsets of CD19+ IgD- memory B cells 4-weeks post immunization within the iLN and spleen. …”